Baird Downgrades Definitive Healthcare to Neutral, Announces $13 Price Target
Portfolio Pulse from richadhand@benzinga.com
Baird analyst Vikram Kesavabhotla has downgraded Definitive Healthcare (NASDAQ:DH) from Outperform to Neutral and set a price target of $13.

July 24, 2023 | 10:00 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Definitive Healthcare has been downgraded from Outperform to Neutral by Baird, with a new price target of $13.
The downgrade from Outperform to Neutral by Baird indicates a less optimistic outlook for the company's stock. The new price target of $13 may also suggest that the analyst believes the stock is currently overvalued, which could lead to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100